Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

The therapeutic responses differed across tumors' locations; the magnitude of the differences of responses across the tumors' locations were drug-dependent. Stratified analysis of the response by tumor location improved drug comparisons and is a powerful tool to understand TL heterogeneity.